Salud financiera de hoja de balance de Think Research

Salud financiera controles de criterios 3/6

Think Research tiene un patrimonio de los accionistas total de CA$28.0M y una deuda total de CA$41.8M, lo que sitúa su ratio deuda-patrimonio en 149.2%. Sus activos y pasivos totales son CA$114.7M y CA$86.7M respectivamente.

Información clave

149.2%

Ratio deuda-patrimonio

CA$41.76m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	CA$3.75m
Patrimonio	CA$27.99m
Total pasivo	CA$86.67m
Activos totales	CA$114.66m

Actualizaciones recientes sobre salud financiera

Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Feb 10

Recent updates

Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Feb 10

Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding

Dec 18

Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge

Sep 06

Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate

Feb 28

Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report

Dec 01

Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long

Mar 30

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CA$19.4M) de THNK no cubren sus pasivos a corto plazo (CA$59.8M).

Pasivo a largo plazo: Los activos a corto plazo (CA$19.4M) de THNK no cubren sus pasivos a largo plazo (CA$26.9M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de THNK (135.8%) se considera alta.

Reducción de la deuda: THNK tenía patrimonio neto negativo hace 5 años, pero ahora es positivo y, por lo tanto, ha mejorado.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: THNK tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.

Pronóstico de cash runway: THNK dispone de suficiente cash runway para 2.8 años si el flujo de caja libre sigue creciendo a tasas históricas de 14% cada año.

Salud financiera de hoja de balance de Think Research

Salud financiera controles de criterios 3/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Think Research (CVE:THNK) Using Debt In A Risky Way?

Recent updates

Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 17.57 million.

Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 17.57 million.

Think Research Corporation, Annual General Meeting, Apr 04, 2024

Beedie Capital entered into an arrangement agreement to acquire remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 25.58 million.

Beedie Capital entered into an arrangement agreement to acquire remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders for CAD 25.58 million.

Is Think Research (CVE:THNK) Using Debt In A Risky Way?

New major risk - Market cap size

Insufficient new directors

New major risk - Share price stability

Little Excitement Around Think Research Corporation's (CVE:THNK) Revenues As Shares Take 28% Pounding

New major risk - Market cap size

New minor risk - Share price stability

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Think Research Corporation to Report Q3, 2023 Results on Nov 27, 2023

Think Research Corporation Appoints Jeffrey Orridge to Its Board of Directors

Why Investors Shouldn't Be Surprised By Think Research Corporation's (CVE:THNK) 26% Share Price Plunge

Price target decreased by 14% to CA$0.73

Second quarter 2023 earnings: EPS exceeds analyst expectations

Think Research Corporation to Report Q2, 2023 Results on Aug 29, 2023

Think Research Corporation Announces Bridge Loan

First quarter 2023 earnings released: CA$0.047 loss per share (vs CA$0.11 loss in 1Q 2022)

Think Research Corporation, Annual General Meeting, Aug 11, 2023

Think Research Corporation to Report Q1, 2023 Results on May 29, 2023

Consensus EPS estimates fall by 17%

Full year 2022 earnings: EPS misses analyst expectations

Think Research Corporation (CVE:THNK) Shares Could Be 48% Below Their Intrinsic Value Estimate

Analysts Have Been Trimming Their Think Research Corporation (CVE:THNK) Price Target After Its Latest Report

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Think Research Corporation to Report Q3, 2022 Results on Nov 28, 2022

High number of new directors

Think Research Appoints John Hayes as Permanent Chief Financial Officer

Consensus revenue estimates fall by 11%

Price target decreased to CA$1.25

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Think Research Corporation to Report Q2, 2022 Results on Aug 29, 2022

Consensus forecasts updated

Think Research Corporation, Annual General Meeting, Aug 02, 2022

Think Research Corporation to Report Q1, 2022 Results on May 30, 2022

Now 26% undervalued after recent price drop

Now 24% undervalued after recent price drop

Full year 2021 earnings: EPS and revenues miss analyst expectations

High number of new directors

Think Research Corporation announced that it expects to receive CAD 25 million in funding from Beedie Capital

Price target decreased to CA$3.08

Think Research Corporation Announces Executive Changes

Think Research Launches Electronic Data Capture System for its Clinical Research Phase 1 Business, Bio Pharma Services Inc

Think Research Corporation Attests to Vendor Verification for Virtual Care in Ontario

CEO & Director recently sold CA$86k worth of stock

Consensus forecasts updated

High number of new directors

Chief Operating Officer Riyaz Lalani has left the company

Think Research Corporation (TSXV:THNK) completed the acquisition of BioPharma Services Inc. from Mahy Investments Ltd., Moske Investments Ltd., N & M Medical Enterprises Inc., Ola Kassim Medicine Professional Corporation and Kashima International Inc. for CAD 43.3 million.

Consensus revenue estimates increase to CA$45.4m

Think Research Corporation (TSXV:THNK) entered into a definitive agreement to acquire BioPharma Services Inc. for CAD 44.6 million.

Think Research Corporation Sees 140% Year-Over-Year Growth for eForms Electronic Data Capture Software in U.S. Post-Acute Care Market

Think Research Corporation Provides Earnings Guidance for the First Quarter Ended March 31, 2021

Analysts Expect Breakeven For Think Research Corporation (CVE:THNK) Before Long

Think Research Partners with Carerx to Deliver Virtualcare Telemedicine Software in Retirement Homes Across Canada

CareRx Corporation and Think Research Corporation Announces Their Canada-Wide Partnership to Deliver Virtual Healthcare to Seniors

Full year 2020 earnings released: CA$0.40 loss per share (vs CA$0.59 loss in FY 2019)

Think Research Corporation (TSXV:THNK) completed the acquisition of Clinic 360 for CAD 5.5 million.

Think Research Corporation (TSXV:THNK) acquired AirMed Trials Inc. for CAD 0.75 million.

Think Research Corporation (TSXV:THNK) entered into a share purchase agreement to acquire mdBriefCase Inc. from PCP GP, L.P. ,Jason Flowerday and others for CAD 24.9 million

Think Research Announces Appointment of Dr. Eric Hoskins to Board of Directors

Think Research Corporation (TSXV:THNK) agreed to acquire Clinic 360 for CAD 5.8 million.

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera